Medroxyprogesterone acetate (depo-prover
โ
M. Steven Piver; Joseph J. Barlow; John R. Lurain; Leslie E. Blumenson
๐
Article
๐
1980
๐
John Wiley and Sons
๐
English
โ 430 KB
A prospective trial was initiated in 1972 utilizing Depo-Provera in women with metastatic or recurrent endometrial adenocarcinoma to evaluate if the objective response and survival would be significantly improved in comparison to patients previously treated with Delalutin at a similar dose. One hund